Effect of subconjunctivally injected liposome-encapsulated tissue plasminogen activator on the absorption rate of subconjunctival hemorrhages in rabbits

Cornea

Volumn 30, Issue 12, 2011, Pages 1455-1460

  Han, Sang Beom ^a   Baek, Seung Hee ^b   Park, Jeong Sook ^c   Yang, Hee Kyung ^a   Kim, Ji Young ^d   Kim, Chong Kook ^e   Hwang, Jeong Min ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Konyang University   (South Korea)

^c Chungnam National University   (South Korea)

^d Seoul National University   (South Korea)

^e Inje University   (South Korea)

Author keywords

liposome; liposome encapsulation; subconjunctival hemorrhage; thrombolytics; tissue plasminogen activator

Indexed keywords

ALTEPLASE; LIPOSOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONJUNCTIVA; CONJUNCTIVAL HEMORRHAGE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; DRUG MECHANISM; NONHUMAN; PLASMA; PRIORITY JOURNAL; RABBIT;

ABSORPTION; ANIMALS; CONJUNCTIVA; CONJUNCTIVAL DISEASES; DISEASE MODELS, ANIMAL; DRUG CARRIERS; EYE HEMORRHAGE; FIBRINOLYTIC AGENTS; INJECTIONS; INJECTIONS, INTRAOCULAR; LIPOSOMES; RABBITS; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 81355146728     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3182120fb9     Document Type: Article

References (20)

1. Verstraete M, Collen D. Thrombolytic therapy in the eighties. Blood. 1986;67:1529-1541.
2. Snyder RW, Lambrou FH, Williams GA. Intraocular fibrinolysis with recombinant human tissue plasminogen activator. Experimental treatment in a rabbit model. Arch Ophthalmol. 1987;105:1277-1280.
3. Lambrou FH, Snyder RW, Williams GA. Use of tissue plasminogen activator in experimental hyphema. Arch Ophthalmol. 1987;105:995-997.
4. Lambrou FH, Snyder RW, Williams GA, et al. Treatment of experimental intravitreal fibrin with tissue plasminogen activator. Am J Ophthalmol. 1987;104:619-623.
5. Borrillo JL, Regillo CD. Treatment of subretinal hemorrhages with tissue plasminogen activator. Curr Opin Ophthalmol. 2001;12:207-211.
6. Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology. 1999;106: 1900-1906.
7. Kwon OW, Kang SJ, Lee JB, et al. Treatment of suprachoroidal hemorrhage with tissue plasminogen activator. Ophthalmologica. 1998;212:120-125.
8. Vine AK, Maguire PT, Martonyi C, et al. Recombinant tissue plasminogen activator to lyse experimentally induced retinal arterial thrombi. Am J Ophthalmol. 1988;105:266-270.
9. Lahey JM, Fong DS, Kearney J. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Ophthalmic Surg Lasers. 1999;30: 427-434.
10. Mimura T, Yamagami S, Funatsu H, et al. Management of subconjunctival haematoma by tissue plasminogen activator. Clin Experiment Ophthalmol. 2005;33:541-542.
11. Kim JY, Kim JK, Park JS, et al. The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator. Biomaterials. 2009;30:5751-5756.
12. Park Y, Liang J, Yang Z, et al. Controlled release of clot-dissolving tissuetype plasminogen activator from a poly(L-glutamic acid) semi-interpenetrating polymer network hydrogel. J Control Release. 2001;75:37-44.
13. Werle M, Bernkop-Schnurch A. Strategies to improve plasma half life time of peptide and protein drugs. Amino Acids. 2006;30:351-367.
14. Lian T, Ho RJ. Trends and developments in liposome drug delivery systems. J Pharm Sci. 2001;90:667-680.
15. Baek SH, Park SJ, Jin SE, et al. Subconjunctivally injected, liposomeencapsulated streptokinase enhances the absorption rate of subconjunctival hemorrhages in rabbits. Eur J Pharm Biopharm. 2009;72:546-451.
16. Moon JW, Song YK, Jee JP, et al. Effect of subconjunctivally injected, liposome-bound, low-molecular-weight heparin on the absorption rate of subconjunctival hemorrhage in rabbits. Invest Ophthalmol Vis Sci. 2006; 47:3968-3974.
17. Adams HP Jr, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke. 1996;27:1711-1718.
18. Yang VC, Naik SS, Song H, et al. Construction and characterization of a t-PA mutant for use in ATTEMPTS: a drug delivery system for achieving targeted thrombolysis. J Control Release. 2005;110:164-176.
19. Broderick JP. Intravenous thrombolysis for acute stroke. Cleve Clin J Med. 2004;71:S28-S30.
20. Groomer AE, Terry JE, Westblom TU. Subconjunctival and external hemorrhage secondary to oral anticoagulation. J Am Optom Assoc. 1990; 61:770-775.